The combination drug valsartan/sacubitril (LCZ696) reduced pulse wave velocity and aortic systolic blood pressure in patients with stable heart failure with reduced ejection fraction

被引：0
|
作者：
Kobalava, Z. [1 ]
Villevalde, S. [1 ]
Tyukhmenev, E. [1 ]
Lukina, O. Olga [1 ]
Babaeva, L. [1 ]
Zharikova, E. [1 ]
机构：
[1] Peoples Friendship Univ Russia, Moscow, Russia
来源：
EUROPEAN JOURNAL OF HEART FAILURE | 2016年 / 18卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P1466
引用
收藏
页码：335 / 335
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of sacubitril/valsartan (LCZ696) in Japanese patients with chronic heart failure and reduced ejection fraction: Rationale for and design of the randomized, double-blind PARALLEL-HF study
    Tsutsui, Hiroyuki
    Momomura, Shinichi
    Saito, Yoshihiko
    Ito, Hiroshi
    Yamamoto, Kazuhiro
    Ohishi, Tomomi
    Okino, Naoko
    Guo, Weinong
    JOURNAL OF CARDIOLOGY, 2017, 70 (3-4) : 225 - 231
  • [22] Long-term sacubitril/valsartan therapy improved central pulse wave parameters in patients with stable heart failure with reduced ejection fraction
    Kobalava, Z.
    Villevalde, S.
    Lukina, O.
    Babaeva, L.
    Meray, I.
    EUROPEAN JOURNAL OF HEART FAILURE, 2017, 19 : 208 - 209
  • [23] Influence of Ejection Fraction on Outcomes and Efficacy of Sacubitril/Valsartan (LCZ696) in Heart Failure with Reduced Ejection Fraction The Prospective Comparison of ARNI with ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure (PARADIGM-HF) Trial
    Solomon, Scott D.
    Claggett, Brian
    Desai, Akshay S.
    Packer, Milton
    Zile, Michael
    Swedberg, Karl
    Rouleau, Jean L.
    Shi, Victor C.
    Starling, Randall C.
    Kozan, Omer
    Dukat, Andrej
    Lefkowitz, Martin P.
    McMurray, John J. V.
    CIRCULATION-HEART FAILURE, 2016, 9 (03)
  • [24] LCZ696 THERAPY IS ASSOCIATED WITH IMPROVEMENT OF VENTRICULAR ARTERIAL COUPLING AND WORK EFFICIENCY IN PATIENTS WITH HEART FAILURE AND REDUCED EJECTION FRACTION
    Kobalava, Z.
    Babaeva, L.
    Lukina, O.
    Zharikova, E.
    Tyukhmenev, E.
    Villevalde, S.
    JOURNAL OF HYPERTENSION, 2016, 34 : E239 - E239
  • [25] A comparison of heart failure patients with reduced ejection fraction in the Moravian Midlands Registry with the LCZ696 patients in the Paradigm-HF trial
    Pavlu, Ludek
    Vicha, Marek
    Flasik, Jakub
    Petrkova, Jana
    Taborsky, Milos
    Kacirkova, Tereza
    Holy, Ondrej
    BIOMEDICAL PAPERS-OLOMOUC, 2024, 168 (03): : 229 - 234
  • [26] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    McCormack, Paul L.
    DRUGS, 2016, 76 (03) : 387 - 396
  • [27] Sacubitril/Valsartan: A Review in Chronic Heart Failure with Reduced Ejection Fraction
    Paul L. McCormack
    Drugs, 2016, 76 : 387 - 396
  • [28] Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Reduced Ejection Fraction
    Arundel, Cherinne
    Lam, Phillip H.
    Gill, Gauravpal S.
    Patel, Samir
    Panjrath, Gurusher
    Faselis, Charles
    White, Michel
    Morgan, Charity J.
    Allman, Richard M.
    Aronow, Wilbert S.
    Singh, Steven N.
    Fonarow, Gregg C.
    Ahmed, Ali
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (24) : 3054 - 3063
  • [29] Effects of Sacubitril/Valsartan on pressure-volume relationship in patients with heart failure and reduced ejection fraction
    Stegmann, T.
    Parentin, L.
    Schirmer, S. H.
    Hagendorff, A.
    Laufs, U.
    Lavall, D.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 28 - 28
  • [30] Implications of pulse wave velocity and central pulse pressure in heart failure with reduced ejection fraction
    Kore, Anette Caroline
    Joonsalu, Tuuli
    Serg, Martin
    Pauklin, Priit
    Voitk, Juri
    Roose, Indrek
    Eha, Jaan
    Kampus, Priit
    BLOOD PRESSURE, 2024, 33 (01)
12345